Table 2.
Summary of identified analytes, their exact mass, and if they are up-regulated (↑) or down-regulated (↓) in female or male CAD or PAD samples
| ID | Exact mass (m/z) | Mass error (ppm) | F CAD | M CAD | PAD |
|---|---|---|---|---|---|
| TMAO | N/A | N/A | ↑ | ↑ | ↑ |
| Choline | (+) 104.1071 | −3.8 | ↑ | ||
| Octylamine | (+) 130.1586 | −7.7 | ↑ | ↑ | ↑ |
| Carnitine | (+) 162.1123 | −4.3 | ↑ | ↑ | |
| γ-hydroxy-L-homoarginine | (+) 205.1271 | −14.6 | ↑ | ↑ | |
| Cholesterol | (+) 369.3511 | 6.8 | ↓ | ↓ | |
| MonoChain-PC | (+) 520.3371 | −6.1 | ↓ | ↓ | |
| MonoChain-PC | (+) 521.3427 | 13.6 | ↓ | ↓ | ↓ |
| MonoChain-PC | (+) 542.3215 | −5.9 | ↓ | ↓ | |
| 20:5 Cholesteryl ester | (+) 671.5742 | −3.7 | ↓ | ↓ | ↓ |
| SM(34:1) | (+) 725.5563 | −1.4 | ↓ | ↓ | |
| PC(34:2) | (+) 759.6366 | −1.2 | ↓ | ↓ | |
| SM(38:1) | (+) 759.5731 | −1.8 | ↓ | ↓ | |
| SM(40:2) | (+) 785.6530 | −0.9 | ↓ | ||
| PC(36:2) | (+) 786.6005 | −1.0 | ↓ | ||
| SM(40:1) | (+) 787.6692 | −0.1 | ↓ | ||
| PC(37:4) | (+) 796.5239 | 43.4 | ↓ | ↓ | |
| PC(38:6) | (+) 806.5662 | −4.7 | ↓ | ↓ | |
| TAG | (+) 848.7687 | −2.4 | ↑ | ||
| TAG | (+) 850.7868 | 0.5 | ↑ | ↑ | |
| TAG | (+) 851.7101 | −3.3 | ↑ | ||
| TAG | (+) 874.7828 | −4.1 | ↑ | ||
| TAG | (+) 876.7995 | −2.9 | ↑ | ↑ | |
| TAG | (+) 877.803 | −22.1 | ↑ | ↑ | |
| TAG | (+) 878.7289 | 5.8 | ↑ | ||
| Salicylic acid | (−) 137.0252 | 4.4 | ↑ | ↑ | ↑ |
| p-cresol sulfate | (−) 187.0064 | −0.5 | ↑ | ↑ |